(-)-demecolcine decreases expression ISO RGD:1312719 6480464 Demecolcine results in decreased expression of SYNE2 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1312719 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SYNE2 mRNA CTD PMID:22079256 (-)-epigallocatechin 3-gallate increases expression ISO RGD:1312719 6480464 epigallocatechin gallate results in increased expression of SYNE2 mRNA CTD PMID:22079256 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of SYNE2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine affects expression EXP 6480464 1, 2-Dimethylhydrazine affects the expression of SYNE2 mRNA CTD PMID:22206623 1,3-benzothiazole-2-thiol decreases expression ISO RGD:1312719 6480464 captax results in decreased expression of SYNE2 mRNA CTD PMID:24211530 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of SYNE2 mRNA CTD PMID:17555576 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1312719 6480464 2 more ... CTD PMID:31675489 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SYNE2 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SYNE2 mRNA CTD PMID:33956508 2-methylcholine affects expression ISO RGD:1312719 6480464 beta-methylcholine affects the expression of SYNE2 mRNA CTD PMID:21179406 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1312719 6480464 tetrabromobisphenol A results in decreased expression of SYNE2 protein CTD PMID:31675489 3-phenylprop-2-enal decreases expression ISO RGD:1312719 6480464 cinnamaldehyde results in decreased expression of SYNE2 mRNA CTD PMID:24211530 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1312719 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of SYNE2 gene CTD PMID:31601247 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of SYNE2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression ISO RGD:1305248 6480464 Propylthiouracil results in increased expression of SYNE2 mRNA CTD PMID:24780913 7beta-aminocephalosporanic acid decreases expression ISO RGD:1312719 6480464 7-aminocephalosporanic acid results in decreased expression of SYNE2 mRNA CTD PMID:24211530 acrolein decreases expression ISO RGD:1312719 6480464 Acrolein results in decreased expression of SYNE2 mRNA CTD PMID:24211530 acrolein multiple interactions ISO RGD:1312719 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SYNE2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SYNE2 mRNA CTD PMID:32699268 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SYNE2 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:1312719 6480464 Aflatoxin B1 results in increased methylation of SYNE2 intron CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO RGD:1312719 6480464 aflatoxin B2 results in increased methylation of SYNE2 intron CTD PMID:30157460 alpha-pinene multiple interactions ISO RGD:1312719 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SYNE2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SYNE2 mRNA CTD PMID:32699268 ammonium hexachloroplatinate decreases expression ISO RGD:1312719 6480464 ammonium hexachloroplatinate results in decreased expression of SYNE2 mRNA CTD PMID:24211530 aristolochic acid decreases expression ISO RGD:1312719 6480464 aristolochic acid I results in decreased expression of SYNE2 mRNA, aristolochic acid I results in decreased expression of SYNE2 protein CTD PMID:33212167 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of SYNE2 mRNA CTD PMID:21715664 benzo[a]pyrene increases methylation ISO RGD:1312719 6480464 Benzo(a)pyrene results in increased methylation of SYNE2 5' UTR, Benzo(a)pyrene results in increased methylation of SYNE2 exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1312719 6480464 Benzo(a)pyrene affects the methylation of SYNE2 3' UTR, Benzo(a)pyrene affects the methylation of SYNE2 intron CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene decreases methylation EXP 6480464 Benzo(a)pyrene results in decreased methylation of SYNE2 exon, Benzo(a)pyrene results in decreased methylation of SYNE2 intron CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1312719 6480464 Benzo(a)pyrene results in decreased methylation of SYNE2 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYNE2 mRNA CTD PMID:27858113 benzo[a]pyrene decreases expression ISO RGD:1312719 6480464 Benzo(a)pyrene results in decreased expression of SYNE2 mRNA CTD PMID:22316170 , PMID:26238291 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1312719 6480464 7 more ... CTD PMID:19150397 , PMID:26238291 benzo[b]fluoranthene decreases expression EXP 6480464 benzo(b)fluoranthene results in decreased expression of SYNE2 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYNE2 mRNA CTD PMID:27858113 benzo[e]pyrene decreases methylation ISO RGD:1312719 6480464 benzo(e)pyrene results in decreased methylation of SYNE2 intron CTD PMID:30157460 bisphenol A affects expression ISO RGD:1305248 6480464 bisphenol A affects the expression of SYNE2 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:1312719 6480464 bisphenol A results in increased methylation of SYNE2 gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:1312719 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of SYNE2 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:1312719 6480464 bisphenol A results in decreased expression of SYNE2 protein CTD PMID:33376534 bisphenol A decreases expression ISO RGD:1305248 6480464 bisphenol A results in decreased expression of SYNE2 mRNA CTD PMID:30816183 , PMID:34947998 butanal decreases expression ISO RGD:1312719 6480464 butyraldehyde results in decreased expression of SYNE2 mRNA CTD PMID:26079696 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 cefaloridine decreases expression ISO RGD:1305248 6480464 Cephaloridine results in decreased expression of SYNE2 mRNA CTD PMID:18500788 CGP 52608 multiple interactions ISO RGD:1312719 6480464 CGP 52608 promotes the reaction [RORA protein binds to SYNE2 gene] CTD PMID:28238834 chloropicrin decreases expression ISO RGD:1312719 6480464 chloropicrin results in decreased expression of SYNE2 mRNA CTD PMID:24211530 chrysene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYNE2 mRNA CTD PMID:27858113 cisplatin multiple interactions ISO RGD:1312719 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SYNE2 mRNA CTD PMID:27392435 cisplatin increases expression ISO RGD:1312719 6480464 Cisplatin results in increased expression of SYNE2 mRNA CTD PMID:27392435 clobetasol decreases expression EXP 6480464 Clobetasol results in decreased expression of SYNE2 mRNA CTD PMID:27462272 coumestrol increases expression ISO RGD:1312719 6480464 Coumestrol results in increased expression of SYNE2 mRNA CTD PMID:19167446 Cuprizon increases expression ISO RGD:1305248 6480464 Cuprizone results in increased expression of SYNE2 mRNA CTD PMID:26577399 DDT decreases expression ISO RGD:1305248 6480464 DDT results in decreased expression of SYNE2 mRNA CTD PMID:30207508 decabromodiphenyl ether decreases expression ISO RGD:1312719 6480464 decabromobiphenyl ether results in decreased expression of SYNE2 protein CTD PMID:31675489 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SYNE2 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1312719 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNE2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1312719 6480464 Doxorubicin results in decreased expression of SYNE2 mRNA CTD PMID:29803840 epichlorohydrin decreases expression ISO RGD:1312719 6480464 Epichlorohydrin results in decreased expression of SYNE2 mRNA CTD PMID:24211530 ethyl methanesulfonate increases expression ISO RGD:1312719 6480464 Ethyl Methanesulfonate results in increased expression of SYNE2 mRNA CTD PMID:23649840 finasteride increases expression ISO RGD:1305248 6480464 Finasteride results in increased expression of SYNE2 mRNA CTD PMID:24136188 flutamide decreases expression ISO RGD:1305248 6480464 Flutamide results in decreased expression of SYNE2 mRNA CTD PMID:24136188 folic acid decreases expression EXP 6480464 Folic Acid results in decreased expression of SYNE2 mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:1312719 6480464 Formaldehyde results in increased expression of SYNE2 mRNA CTD PMID:27664576 fulvestrant multiple interactions ISO RGD:1312719 6480464 [bisphenol A co-treated with Fulvestrant] affects the methylation of SYNE2 gene CTD PMID:31601247 glafenine decreases expression ISO RGD:1305248 6480464 Glafenine results in decreased expression of SYNE2 mRNA CTD PMID:24136188 glycidol decreases expression ISO RGD:1305248 6480464 glycidol results in decreased expression of SYNE2 mRNA CTD PMID:24395379 hexamethylene diisocyanate decreases expression ISO RGD:1312719 6480464 1, 6-hexamethylene diisocyanate results in decreased expression of SYNE2 mRNA CTD PMID:24211530 hydrogen peroxide multiple interactions EXP 6480464 [Hydrogen Peroxide co-treated with N-(oxo-5 more ... CTD PMID:31494107 ivermectin decreases expression ISO RGD:1312719 6480464 Ivermectin results in decreased expression of SYNE2 protein CTD PMID:32959892 lead(0) affects splicing ISO RGD:1312719 6480464 Lead affects the splicing of SYNE2 mRNA CTD PMID:28903495 lead(2+) affects splicing ISO RGD:1312719 6480464 Lead affects the splicing of SYNE2 mRNA CTD PMID:28903495 methapyrilene decreases methylation ISO RGD:1312719 6480464 Methapyrilene results in decreased methylation of SYNE2 intron CTD PMID:30157460 methyl methanesulfonate increases expression ISO RGD:1312719 6480464 Methyl Methanesulfonate results in increased expression of SYNE2 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1312719 6480464 methylmercuric chloride results in decreased expression of SYNE2 mRNA CTD PMID:28001369 N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of SYNE2 intron CTD PMID:27776689 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SYNE2 protein CTD PMID:26558463 nefazodone decreases expression ISO RGD:1305248 6480464 nefazodone results in decreased expression of SYNE2 mRNA CTD PMID:24136188 ozone multiple interactions ISO RGD:1312719 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SYNE2 mRNA more ... CTD PMID:32699268 paracetamol decreases expression ISO RGD:1312719 6480464 Acetaminophen results in decreased expression of SYNE2 mRNA CTD PMID:21420995 PCB138 multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 picoxystrobin decreases expression ISO RGD:1312719 6480464 picoxystrobin results in decreased expression of SYNE2 mRNA CTD PMID:33512557 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of SYNE2 mRNA CTD PMID:18445702 potassium chromate decreases expression ISO RGD:1312719 6480464 potassium chromate(VI) results in decreased expression of SYNE2 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1312719 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SYNE2 mRNA CTD PMID:22079256 rotenone decreases expression ISO RGD:1305248 6480464 Rotenone results in decreased expression of SYNE2 mRNA CTD PMID:28374803 rotenone decreases expression ISO RGD:1312719 6480464 Rotenone results in decreased expression of SYNE2 mRNA CTD PMID:33512557 SB 431542 multiple interactions ISO RGD:1312719 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNE2 mRNA CTD PMID:27188386 sunitinib decreases expression ISO RGD:1312719 6480464 Sunitinib results in decreased expression of SYNE2 mRNA CTD PMID:31533062 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of SYNE2 mRNA CTD PMID:20937368 tebufenpyrad decreases expression ISO RGD:1312719 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of SYNE2 mRNA CTD PMID:33512557 tetrachloromethane decreases expression ISO RGD:1305248 6480464 Carbon Tetrachloride results in decreased expression of SYNE2 mRNA CTD PMID:30723492 tetraphene decreases expression EXP 6480464 benz(a)anthracene results in decreased expression of SYNE2 mRNA CTD PMID:26377693 tetraphene multiple interactions EXP 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of SYNE2 mRNA CTD PMID:27858113 thimerosal decreases expression ISO RGD:1312719 6480464 Thimerosal results in decreased expression of SYNE2 mRNA CTD PMID:27188386 thiram decreases expression ISO RGD:1312719 6480464 Thiram results in decreased expression of SYNE2 mRNA CTD PMID:24211530 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of SYNE2 mRNA CTD PMID:29264374 trichostatin A decreases expression ISO RGD:1312719 6480464 trichostatin A results in decreased expression of SYNE2 mRNA CTD PMID:24935251 trichostatin A multiple interactions ISO RGD:1312719 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SYNE2 mRNA CTD PMID:27188386 triptonide increases expression EXP 6480464 triptonide results in increased expression of SYNE2 mRNA CTD PMID:33045310 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of SYNE2 mRNA CTD PMID:28973697 valproic acid decreases expression ISO RGD:1312719 6480464 Valproic Acid results in decreased expression of SYNE2 mRNA CTD PMID:23179753 , PMID:28001369 valproic acid decreases expression ISO RGD:1305248 6480464 Valproic Acid results in decreased expression of SYNE2 mRNA CTD PMID:29427782 vincristine decreases expression ISO RGD:1312719 6480464 Vincristine results in decreased expression of SYNE2 mRNA CTD PMID:23649840 vorinostat decreases expression ISO RGD:1312719 6480464 vorinostat results in decreased expression of SYNE2 mRNA CTD PMID:27188386
